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Abstract
Background: The aim of this study was to develop an assessment tool for activities of daily living (ADL) from
the perspective of patients with Parkinson’s disease (PD) and examine the validity and reliability of the
assessment.
Methods: A preliminary 45-item questionnaire was developed through intensive interviews with 54 patients
with PD and administered to another group of 248 patients with PD. Based on clinical and statistical analyses,
20 ADL-items were selected. The final 20-item questionnaire was examined in the other group of 59 patients
with PD.
Results: The new ADL questionnaire showed high internal consistency (Cronbach’s α, 0.962–0.966) and
acceptable test-retest reliability (0.632–0.984). Concurrent validity was shown as a significant positive
correlation between the new ADL questionnaire and other ADL or clinical instruments. The Hoehn and Yahr
stage showed the highest degree of correlation with the new ADL questionnaire, followed by the other ADL
scales (Schwab and England ADL and the ADL subscore of the Unified Parkinson’s Disease Rating Scale).
Additionally, a regression analysis was conducted with the disease-specific quality of life questionnaire, and
the new ADL questionnaire was the most powerful predictor of quality of life among the clinical
instruments.
Conclusions: The new ADL questionnaire is a valid tool for assessing ADL from the perspectives of patients
with PD.
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Background
Parkinson’s disease (PD) is a chronic disorder due to the
progressive degeneration of dopamine-producing cells in
brain structures, including the substantia nigra [1]. PD is
characterized by motor disturbances, such as tremor,
bradykinesia, rigidity, and postural instability. Clinical
presentations of PD also include a variety of non-motor
symptoms. Thus, patients with PD are vulnerable to de-
creased activities of daily living (ADL), such as walking,
talking, swallowing, or simple tasks like bathing or
dressing [2].
Despite the recent development of medical, surgical,
and rehabilitative treatments, PD remains a progressive
condition; there are no proven management strategies to
reverse or halt its pathological processes. Patients with
PD are at increased risk for decreased activities of daily
living (ADL) with progression of the disease, particularly
those requiring coordination and balance [3–5]. The
treatment goal for patients with PD is to focus on symp-
toms and improve ADL. Therefore, it is mandatory to
assess the ADL of patients with PD, which is essential
for evaluating the effectiveness of symptomatic and po-
tentially disease-modifying treatments.
Some studies have focused on the ADL of patients
with PD. However, these studies have revealed limita-
tions due to a lack of reliable and valid tools for
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assessing ADL from the patient’s perspective [6–10].
The Unified Parkinson’s Disease Rating Scale
(UPDRS) is widely used to assess mentation, ADL,
motor symptoms, and treatment complications in
patients with PD [11]. The advantages of the ADL
subsection of the UPDRS have been well described
[12, 13]. However, it has been criticized due to its
ambiguity and redundancy of items, such as items
overlapping in the ADL and motor sections, and a
lack of the patient’s perspective has also been re-
ported [11, 14]. It also requires an interview by an
examiner. The new version of the UPDRS includes motor
experiences associated with ADL that are self-evaluated
by patients or their caregivers [14]. However, the new ver-
sion does not differ greatly from the old version and fails
to evaluate ADL comprehensively.
Improvements in motor symptoms, which are unre-
sponsive to medical and surgical treatments, have been
observed in patients with PD with recent advancements
in rehabilitation therapy [15]. These symptoms are re-
lated to balance, walking, and mobility, all of which con-
stitute the ADL of patients with PD. However, the
UPDRS shows limited validity for assessing the effects of
physiotherapy on balance and mobility, both of which
are essential when measuring the ADL of patients with
PD [16].
We developed a new ADL questionnaire from the pa-
tient’s perspective and assessed its validity and reliability
in this cross-sectional study.
Methods
Study patients
Patients with PD were recruited consecutively from an
outpatient clinic in a specialized center of a referral hos-
pital. Patients were diagnosed with clinically probable
PD according to the United Kingdom Parkinson’s Dis-
ease Society Brain Bank clinical diagnostic criteria [17].
Patients with cognitive impairment based on a Korean
Mini-Mental Status Examination (K-MMSE) score < 24
and patients without sufficient cognitive or physical abil-
ity to cooperate were excluded [18]. Patients who had
other medical problems that seriously affected ADL,
such as stroke, osteoarthritis, and angina, were also
excluded.
Development of the preliminary 45-item questionnaire
Movement disorder and neurorehabilitation specialists
reviewed motor aspects of disabilities of daily living
in patients with PD with reference to various ADL
scales and collected ADL items [19–25]. An open and
intensive interview was performed with 54 patients
with PD; they were asked whether they had disability
in a collection of ADL items and were asked to add
any other ADL items experienced during their daily
lives. The preliminary 45-item ADL questionnaire was
prepared and included household, outdoor, and social
activities (Appendix 1).
Selection of the final 20-item questionnaire
Another group of 248 patients with PD (90 men and 158
women; mean age, 67.9 ± 9.2 years; mean K-MMSE
score, 26.2 ± 3.8 points; mean Hoehn and Yahr [HY]
stage, 2.4 ± 0.6) were asked to select the items that they
found difficult in their daily living and were asked to se-
lect the three items that were most important to them
using the preliminary 45-item questionnaire.
Clinical and statistical analyses were performed to
select the ADL items. The frequency of items reflect-
ing patient’s experience and importance and clinical
significance for infrequent items, such as swallowing,
were included in the clinical analyses. Statistical ana-
lyses were conducted using maximum likelihood to
estimate the factor structure matrix. The number of
items was determined using parallel analysis and the
scree test. We used the Promax (Kappa = 2) oblique
rotation method to simplify the structure, and each
item was selected and classified based on a factor
loading > 0.4.
All items were given a score on a 5-point scale (0: no
impairment of ADL and 5: inability to perform ADL)
(Appendix 2).
Validation of the final 20-item questionnaire
Fifty-nine patients with mild-to-moderate PD were
additionally recruited to validate the final 20-item
questionnaire (Table 1). We assessed internal consistency
of the new ADL questionnaire using Cronbach’s α. In
addition, we performed repeated interviews at a 4-week
interval to assess test-retest reliability. Concurrent validity
was analyzed by the correlation between the new ADL
questionnaire and other clinical instruments including the
UPDRS, the Schwab and England ADL (SEADL) scale,
Beck’s Depression Inventory [26], the Autonomic Dys-
function Questionnaire [27], the Fatigue Severity Scale
[28], and the Parkinson’s disease quality of life (PDQL)
questionnaire [29]. A simple regression analysis was con-
ducted for the PDQL questionnaire to evaluate the influ-
ence of various clinical instruments on quality of life.
Statistical analysis
All data are expressed as mean ± standard deviation
for continuous variables and as proportions of pa-
tients (%) for categorical variable. The univariate ana-
lysis included Student’s t-test and Pearson’s chi-square
test, as appropriate, to analyze differences between
the two groups. A correlation analysis was conducted
using Spearman’s method. The statistical analysis was
performed using SPSS ver. 19.0 for Windows software
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(SPSS Inc., Chicago, IL, USA). A P-value ≤ 0.05 was
considered significant.
Results
Evaluation of ADL with the preliminary 45-item
questionnaire in 248 patients with PD
The most common ADL items experienced by pa-
tients were getting up (61.7 %), dressing (57.7 %), and
moving objects (56.9 %) (Table 2). The most import-
ant ADL items selected by patients were “walking
outside”, “using a spoon and chopsticks”, and “getting
up”. Some differences in the frequencies for selected
items were detected according to sex, such as “driv-
ing” for men, “preparing a meal”, “washing dishes”,
“cleaning”, and “washing clothes” for women (chi-
square test, P ≤ 0.05).
A positive correlation was observed between the num-
ber of items patients found difficult and severity of the
disease, as shown by the HY stage (Table 3).
Validation of the new ADL questionnaire in 59 patients
with PD
The internal consistency of the new questionnaire
was acceptable with an item-total correlation (range,
0.523–0.898) and high consistency, as shown by
Table 2 The most common disabilities during daily activities in
patients with Parkinson’s disease using the preliminary 45-item
questionnaire
Items of ADL Number Percent
Getting up from the floor 153 61.7
Dressing 143 57.7
Moving objects 141 56.9
Wearing shoes 136 54.8
Writing 134 54.0
Walking inside 133 53.6
Walking outside 131 52.8
Standing 130 52.4
Turning around in bed 126 50.8
Sitting on the floor 126 50.8
ADL Activities of Daily Living
Table 1 Baseline and clinical characteristics of the 59 patients
who were evaluated to validate the 20-item questionnaire
Mean ± SD
Number (male-to-female ratio) 59 (22:37)
Age (years) 66.85 ± 8.25
Disease duration (years) 6.14 ± 4.80
Treatment duration (years) 4.43 ± 4.00
The daily dose of levodopa (mg/day) 540.00 ± 296.21
K-MMSE 26.49 ± 2.85
New questionnaire 23.24 ± 22.29
HY stage 2.42 ± 0.58
UPDRS 45.78 ± 18.49
Mentation 3.26 ± 2.05
ADL 11.88 ± 6.22
Motor 27.91 ± 11.05
Complications 2.73 ± 2.97
SEADL 77.59 ± 15.89
BDI 22.38 ± 11.53
PDQL 115.53 ± 39.93
Parkinson’s symptoms 42.51 ± 14.14
Systemic symptoms 25.27 ± 9.64
Social function 19.21 ± 7.18
Emotional function subscore 28.54 ± 10.80
ADQ 19.21 ± 12.42
FSS 36.20 ± 15.69
K-MMSE Korean Mini-Mental Status Examination, HY Hoehn and Yahr, UPDRS
Unified Parkinson’s Disease Rating Scale, ADL Activities of Daily Living, SEADL
Schwab and England ADL, BDI Beck’s Depression Inventory, PDQL Parkinson’s
Disease Quality of Life, ADQ Autonomic Dysfunction Questionnaire, FSS Fatigue
Severity Scale
Table 3 The most common and important items in patients
with Parkinson's disease according to Hoehn and Yahr stage
using the preliminary 45 item questionnaire
HY
stage
Number of items Most common items Most important items
1 1.29 ± 1.60 Getting up from
the floor
Exercise
Sitting on the floor Walking outside
Walking outside Grasping and
releasing objects
2 11.31 ± 11.06 Dressing Walking outside
Getting up from
the floor
Getting up from the
floor
Writing Using a spoon and
chopsticks
2.5 20.30 ± 12.04 Getting up from
the floor
Walking outside
Transferring objects Sitting on the floor
Wearing shoes Getting up from
the floor
3 24.18 ± 12.81 Getting up from
the floor
Walking outside
Moving objects Taking the first step
Taking the first step Getting in/out of bed




Taking a bath/shower Getting in/out of bed
HY Hoehn and Yahr
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Cronbach’s α of 0.962–0.966. Test-retest reliability
was acceptable, reached at 0.632–0.984. Concurrent
validity was detected as significant correlations be-
tween scores on the new ADL questionnaire and
other ADL scales (SEADL and the ADL subscore of
the UPDRS). The other clinical instruments were also
correlated with the new ADL questionnaire, except
the MMSE (Table 4).
The regression analysis for quality of life showed
that the new ADL questionnaire was the most power-
ful predictor for quality of life in patients with PD
followed by the ADL subscore of the UPDRS
(Table 5). The new questionnaire and the ADL sub-
score of the UPDRS were the strongest predictors of
the PDQL after adjusting for age, disease duration,
treatment, and daily levodopa dosage (adjusted R2
values, 0.456 and 0.464, respectively).
Discussion
The number of ADL items that were difficult for pa-
tients with PD increased according to the HY stage
using the 45-item questionnaire, indicating that pro-
gression of the disease increased ADL impairment.
This finding suggests that items on the preliminary
questionnaire covered ADL throughout the disease
stages and comprehensively reflected the patient’s
perspectives.
Some differences were found in the list of selected
items according to HY stage. However, the most com-
mon and important items for the patients were simi-
lar at all HY stages. Getting up was the most
common, and walking outside was the most import-
ant activity. These findings suggest that mobility de-
serves special attention compared to others activities
during the daily lives of these patients.
Among the most frequently selected 10 items, only
four (dressing, writing, walking, and turning around in
bed) are present in the ADL section of the UPDRS.
These findings suggest that the ADL section of the
UPDRS may be insufficient to reflect the daily disabil-
ities of patients with PD.
The validity of the new questionnaire was acceptable,
as shown by the correlation with other clinical measures.
Concurrent validity was reasonable based on the high
correlation of the new questionnaire with other ADL
and clinical instruments, except the K-MMSE. Given
that cognitive function can greatly affect ADL, this result
may be distorted due to the limited distribution of the
K-MMSE scores based on the exclusion criteria of this
study. The new questionnaire showed the highest degree
of correlation with HY stage and also had a high degree
of correlation with other clinical instruments, such as
the SEADL and the ADL section of the UPDRS. More-
over, the motor subscore of the UPDRS was marginally
correlated with the new ADL questionnaire, but it was
less correlated than depression, autonomic dysfunction,













Parkinson’s symptoms’ −0.596 <0.001
Systemic symptoms’ −0.527 <0.001
Social function’ −0.589 <0.001
Emotional function’ −0.594 <0.001
ADQ 0.480 0.000
FSS 0.449 0.001
K-MMSE Korean Mini-Mental Status Examination, HY Hoehn and Yahr, SEADL
Schwab and England ADL, UPDRS Unified Parkinson’s Disease Rating Scale,
ADL Activities of Daily Living, BDI Beck’s Depression Inventory, PDQL
Parkinson’s Disease Quality of Life, ADQ Autonomic Dysfunction Questionnaire,
FSS Fatigue Severity Scale
Table 5 Results of a simple regression analysis for the
Parkinson’s Disease Quality of Life Score
P-value R2
New questionnaire <0.001 0.366
K-MMSE 0.746 0.002










K-MMSE Korean Mini-Mental Status Examination, HY Hoehn and Yahr, SEADL
Schwab and England ADL, UPDRS Unified Parkinson’s Disease Rating Scale,
ADL Activities of Daily Living, BDI Beck’s Depression Inventory, ADQ Autonomic
Dysfunction Questionnaire, FSS Fatigue Severity Scale
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and fatigue. This finding is consistent with a recent re-
port that severity of motor symptoms, as expressed by
the motor subscore of the UPDRS, has less impact on
the health status of patients with PD than non-motor
symptoms [30].
Quality of life may be the most important clinical
measure representing the current status of patients with
PD. Our results show that the new questionnaire was a
strong predictor of quality of life in patients with PD
among the clinical instruments evaluated in this study.
A regression analysis showed that the new questionnaire
and the ADL subscore of the UPDRS had strong predict-
ive value for quality of life in patients with PD after
adjusting of for age, disease duration, treatment, and
daily levodopa dosage.
Several limitations of this study should be dis-
cussed. Different importance could be assigned to
some items in different cultures, such as “getting up
from or sitting on the floor”. Thus, it may be neces-
sary to validate the new questionnaire in different
cultural areas. Also, there could be some biases from
the predominance women in recruited patients at
the evaluation of preliminary 45-item questionnaire.
And, the new questionnaire showed relatively weak
correlation with motor part of UDPRS, compared to
other scales. This finding could suggest that the new
questionnaire might not be sensitive enough as an
assessment tool for motor changes responsive to
physical therapy. Finally, this study was conducted
using a cross-sectional design. Therefore, we failed
to assess the feasibility of the new questionnaire for
detecting changes along the course of the disease.
This deserves further longitudinal studies.
Despite these limitations, the new questionnaire has
several advantages over other clinical instruments; it re-
flects actual patient disabilities during daily living based
on a patient’s perspective. Changes in the ADL of pa-
tients could be easily and effectively evaluated, because
the questionnaire is designed for self-administration.
Thus, the new questionnaire is applicable to long-term
follow-up in an actual clinical setting.
Conclusion
The new questionnaire developed based on the perspec-
tive of patients with PD was found to be a valid tool for
assessing ADLs of patients with PD.
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Table 6 Preliminary 45-item questionnaire
Please check the daily activities that you find difficult to do during last
week. Please list the three activities that are most important to you.
Household Outdoor
Getting in/out of bed Taking the first step
Turning around in bed Walking outside
Sitting on the floor Turning
Getting up from the floor Stopping walking
Dressing Walking up/down stairs
Sex life Crossing the street
Running
Sitting on and rising from a chair Getting in/out of a car
Sitting upright Getting on/off of a bus or
subway
Standing Driving a car
Walking inside
Grasping and releasing an object If you (or the patient)
cannot walk
Moving an object Moving from the bed or
a chair to a wheelchair




Getting in/out of the bath Using the phone
Taking a bath/shower Shopping
Using the toilet Going out
Walking around the
neighborhood





Washing the dishes Traveling
Cleaning the house
Washing the clothes Activities most important
for you.
1.
If you find any other activities
difficult that are not in this list,
please list them below.
2.
3.
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Appendix 2
Table 7 The new activities of daily living questionnaire
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